| 标题 |
[高分]
Efficacy and safety of mirikizumab as induction and maintenance therapy in patients with moderately to severely active Crohn’s disease: Summary results from the Phase 3 VIVID-1 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Zeitschrift für Gastroenterologie 作者:B. Siegmund; M. Ferrante; V. Jairath; G. D’Haens; S. Maier; et al 出版日期:2024-10-03 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)